Bellei B, Migliano E, Picardo M
Cancers (Basel). 2020; 12(11).
PMID: 33212834
PMC: 7697272.
DOI: 10.3390/cancers12113400.
Bertrand J, Steingrimsson E, Jouenne F, Bressac-de Paillerets B, Larue L
Acta Derm Venereol. 2020; 100(11):adv00139.
PMID: 32346747
PMC: 9189750.
DOI: 10.2340/00015555-3494.
Cho J, Kim S, Kim Y, Sim M, Kim S, Kim N
Clin Transl Oncol. 2017; 19(10):1247-1252.
PMID: 28421416
DOI: 10.1007/s12094-017-1662-x.
Yun W, Kim E, Park J, Jo S, Bang S, Chang E
Sci Rep. 2016; 6:19914.
PMID: 26814135
PMC: 4728609.
DOI: 10.1038/srep19914.
Li J, Ji L, Chen J, Zhang W, Ye Z
Biomed Res Int. 2015; 2015:964842.
PMID: 26078973
PMC: 4452418.
DOI: 10.1155/2015/964842.
The role of the hippo pathway in melanocytes and melanoma.
Kim J, Finlay G, Baguley B
Front Oncol. 2013; 3:123.
PMID: 23720711
PMC: 3655322.
DOI: 10.3389/fonc.2013.00123.
WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.
Yang P, Anastas J, Toroni R, Shinohara M, Goodson J, Bosserhoff A
EMBO Mol Med. 2012; 4(12):1294-307.
PMID: 23129487
PMC: 3531604.
DOI: 10.1002/emmm.201201486.
Modeling melanoblast development.
Larue L, De Vuyst F, Delmas V
Cell Mol Life Sci. 2012; 70(6):1067-79.
PMID: 22915137
PMC: 11113344.
DOI: 10.1007/s00018-012-1112-4.
Regulating the response to targeted MEK inhibition in melanoma: enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation.
Conrad W, Swift R, Biechele T, Kulikauskas R, Moon R, Chien A
Cell Cycle. 2012; 11(20):3724-30.
PMID: 22895053
PMC: 3495814.
DOI: 10.4161/cc.21645.
Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
Tarapore R, Siddiqui I, Mukhtar H
Carcinogenesis. 2011; 33(3):483-91.
PMID: 22198211
PMC: 3384069.
DOI: 10.1093/carcin/bgr305.
Neural cell adhesion molecule potentiates the growth of murine melanoma via β-catenin signaling by association with fibroblast growth factor receptor and glycogen synthase kinase-3β.
Liu R, Shi Y, Yang H, Wang L, Zhang S, Xia Y
J Biol Chem. 2011; 286(29):26127-37.
PMID: 21628472
PMC: 3138257.
DOI: 10.1074/jbc.M111.237297.
Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekstrom E, Sherwood V, Andersson T
PLoS One. 2011; 6(4):e18674.
PMID: 21494614
PMC: 3072980.
DOI: 10.1371/journal.pone.0018674.
WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition.
Ho H, Kapadia R, Al-Tahan S, Ahmad S, Ganesan A
J Biol Chem. 2011; 286(14):12509-23.
PMID: 21317285
PMC: 3069453.
DOI: 10.1074/jbc.M110.200543.
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.
Tap W, Gong K, Dering J, Tseng Y, Ginther C, Pauletti G
Neoplasia. 2010; 12(8):637-49.
PMID: 20689758
PMC: 2915408.
DOI: 10.1593/neo.10414.
Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
Chien A, Moore E, Lonsdorf A, Kulikauskas R, Rothberg B, Berger A
Proc Natl Acad Sci U S A. 2009; 106(4):1193-8.
PMID: 19144919
PMC: 2626610.
DOI: 10.1073/pnas.0811902106.
Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.
Grigoryan T, Wend P, Klaus A, Birchmeier W
Genes Dev. 2008; 22(17):2308-41.
PMID: 18765787
PMC: 2749675.
DOI: 10.1101/gad.1686208.
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.
Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M
Genes Dev. 2007; 21(22):2923-35.
PMID: 18006687
PMC: 2049194.
DOI: 10.1101/gad.450107.
The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis.
Bauer A, Stratakis C
J Med Genet. 2005; 42(11):801-10.
PMID: 15958502
PMC: 1735945.
DOI: 10.1136/jmg.2003.017806.